81 results on '"Langerød A"'
Search Results
2. 103P Impact of Prosigna test on treatment decision in lymph node-negative early breast cancer: A prospective multicenter study (EMIT1)
3. Supplementary Figures S1-S5, Tables 1-3 from Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53
4. Supplementary Figures S1-S5, Tables 1-3 from Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53
5. Supplementary figures from Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
6. Supplementary Figure 7 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
7. Supplementary Tables from The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
8. Data from Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
9. Supplementary Figure 2 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
10. Data from Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
11. Supplementary Figure 6 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
12. Supplementary Figure 4 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
13. Supplementary Figure 5 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
14. Supplementary Figure 3 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
15. Supplementary Figure 8 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
16. Supplementary Figure Legends from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
17. Supplementary figures from Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
18. Supplementary Figure 1 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
19. Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers
20. Comparing 5-Year Survival Rates Before and After Re-stratification of Stage I–III Right-Sided Colon Cancer Patients by Establishing the Presence/Absence of Occult Tumor Cells and Lymph Node Metastases in the Different Levels of Surgical Dissection
21. Sounds familiar(?): Expertise with specific musical genres modulates timing perception and micro-level synchronization to auditory stimuli
22. Assessing TP53 Status in Human Tumors: Lessons from Breast Cancer
23. Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of the gene regulatory program in cancers
24. A comparison of methods for investigating the perceptual center of musical sounds
25. Where is the beat in that note? Effects of attack, duration, and frequency on the perceived timing of musical and quasi-musical sounds.
26. Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences
27. The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
28. Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
29. Assessment ofTP53Polymorphisms andMDM2SNP309 in Premenopausal Breast Cancer Risk
30. TP53Mutations in Breast and Ovarian Cancer
31. Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
32. Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer
33. Landscape of somatic mutations in 560 breast cancer whole-genome sequences
34. The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
35. The Life History of 21 Breast Cancers
36. Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53
37. Abstract PR06: Lymphocyte invasion of basal breast tumors is associated with wild-type p53
38. Tilbake til hverdagen
39. TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
40. AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53
41. AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma
42. Mutational Processes Molding the Genomes of 21 Breast Cancers
43. The Life History of 21 Breast Cancers
44. Tilbake til hverdagen
45. Functional characterization of the 19q12 amplicon in grade III breast cancers
46. Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
47. Har kroppsvekt betydning for bentettheten hos eldre menn?
48. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups
49. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters
50. Combining Gene Signatures Improves Prediction of Breast Cancer Survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.